Nitrergic Response TO Cyclophosphamide Treatment in Blood and Bone Marrow

Daily intraperitoneal injection of cyclophosphamide (CPA) (50 mg∙kg(-1) of body weight) for 5 days resulted in reduced levels of marrow and blood cellularity, which was most pronounced in 18 days post-treatment (pt). On day 18 after CPA treatment the enhancedlevels of nitric oxide (NO) precursors an...

Descripción completa

Detalles Bibliográficos
Autores principales: Kevorkian, G.A, Alchujyan, N.Kh, Movsesyan, N.H, Hayrapetyan, H.L, Guevorkian, A.G, Ohanyan, R.M, Dagbashyan, S.S
Formato: Texto
Lenguaje:English
Publicado: Bentham Open 2008
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2570548/
https://www.ncbi.nlm.nih.gov/pubmed/18949079
http://dx.doi.org/10.2174/1874091X00802010081

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2570548/
https://www.ncbi.nlm.nih.gov/pubmed/18949079
http://dx.doi.org/10.2174/1874091X00802010081

Ejemplares similares